Active Surveillance for Intermediate Risk Prostate Cancer

Por Dall'Era, Marc A., Klotz, Laurence
Publicado no Prostate Cancer Prostatic Dis (2016)

Contemporary management of muscle-invasive bladder cancer

Por Dall’Era, Marc A, Cheng, Liang, Pan, Chong-Xian
Publicado em 2012

Active Surveillance for Prostate Cancer Compared With Immediate Treatment: An Economic Analysis

Por Keegan, Kirk A., Dall'Era, Marc A., Durbin-Johnson, Blythe, Evans, Christopher P.
Publicado em 2011

Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour

Por Pugashetti, Neil, Yap, Stanley A., Lara, Primo N., Gandour-Edwards, Regina, Dall’Era, Marc A.
Publicado no Can Urol Assoc J (2015)

Validation study of a computer-based open surgical trainer: SimPraxis(®) simulation platform

Por Tran, Linh N, Gupta, Priyanka, Poniatowski, Lauren H, Alanee, Shaheen, Dall’Era, Marc A, Sweet, Robert M
Publicado em 2013

Differential expression of CD10 in prostate cancer and its clinical implication

Por Dall'Era, Marc A, True, Lawrence D, Siegel, Andrew F, Porter, Michael P, Sherertz, Tracy M, Liu, Alvin Y
Publicado em 2007

Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?

Por Chandrasekar, Thenappan, Pugashetti, Neil, Durbin-Johnson, Blythe, Dall’Era, Marc A., Evans, Christopher P., deVere White, Ralph W., Yap, Stanley A.
Publicado no Bladder Cancer (2016)

A Phase II clinical trial of everolimus plus bicalutamide for castration-resistant prostate cancer

Por Chow, Helen, Ghosh, Paramita M, White, Ralph deVere, Evans, Christopher P., Dall'Era, Marc A., Yap, Stanley A., Li, Yueju, Beckett, L. A., Lara, Primo N., Pan, Chong-xian
Publicado no Cancer (2016)

Cardiopulmonary bypass (CPB) has no significant impact on survival in patients undergoing nephrectomy and level III-IV inferior vena cava thrombectomy; a multi-institutional analys...

Por Nguyen, Hao G., Tilki, Derya, Dall'Era, Marc A., Durbin-Johnson, Blythe, Carballido, Joaquín A., Chandrasekar, Thenappan, Chromecki, Thomas, Ciancio, Gaetano, Daneshmand, Siamak, Gontero, Paolo, Gonzalez, Javier, Haferkamp, Axel, Hohenfellner, Markus, Huang, William C., Espinós, Estefania Linares, Mandel, Philipp, Martinez-Salamanca, Juan I., Master, Viraj A., McKiernan, James M., Montorsi, Francesco, Novara, Giacomo, Pahernik, Sascha, Palou, Juan, Pruthi, Raj S., Rodriguez-Faba, Oscar, Russo, Paul, Scherr, Douglas S., Shariat, Shahrokh F., Spahn, Martin, Terrone, Carlo, Vergho, Daniel, Wallen, Eric M., Xylinas, Evanguelos, Zigeuner, Richard, Libertino, John A., Evans, Christopher P.
Publicado no J Urol (2015)

Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Por Zargar, Homayoun, Espiritu, Patrick N., Fairey, Adrian S., Mertens, Laura S., Dinney, Colin P., Mir, Maria C., Krabbe, Laura-Maria, Cookson, Michael S., Jacobsen, Niels-Erik, Gandhi, Nilay, Griffin, Joshua, Montgomery, Jeffrey S., Vasdev, Nikhil, Yu, Evan Y., Youssef, David, Xylinas, Evanguelos, Campain, Nicholas J., Kassouf, Wassim, Dall’Era, Marc A., Seah, Jo-An, Ercole, Cesar E., Horenblas, Simon, Sridhar, Srikala S., McGrath, Jonathan S., Aning, Jonathan, Shariat, Shahrokh F., Wright, Jonathan L., Thorpe, Andrew C., Morgan, Todd M., Holzbeierlein, Jeff M., Bivalacqua, Trinity J., North, Scott, Barocas, Daniel A., Lotan, Yair, Garcia, Jorge A., Stephenson, Andrew J., Shah, Jay B., van Rhijn, Bas W., Daneshmand, Siamak, Spiess, Philippe E., Black, Peter C.
Publicado no Eur Urol (2014)